Inj, gadopiclenol, 1 ml
Products billed under this code include Elucirem, Vueway.
Payment limit per 1 ML, by effective quarter, 2Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under A9573
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Elucirem | Guerbet LLC | 67684-4230-02 | 30 | $96.66 |
| Elucirem | Guerbet LLC | 67684-4231-02 | 75 | $241.65 |
| Elucirem | Guerbet LLC | 67684-4232-02 | 100 | $322.20 |
| Elucirem | Guerbet LLC | 67684-4240-02 | 75 | $241.65 |
| Elucirem | Guerbet LLC | 67684-4241-02 | 100 | $322.20 |
| Elucirem | Guerbet LLC | 67684-4250-04 | 1250 | $4,027.50 |
| Vueway | Bracco Diagnostics Inc. | 00270-7015-46 | 750 | $2,416.50 |
| Vueway | Bracco Diagnostics Inc. | 00270-7015-48 | 1250 | $4,027.50 |
| Vueway | Bracco Diagnostics Inc. | 00270-7020-38 | 30 | $96.66 |
| Vueway | Bracco Diagnostics Inc. | 00270-7025-40 | 75 | $241.65 |
Show all 11 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vueway | Bracco Diagnostics Inc. | 00270-7030-42 | 100 | $322.20 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.222 | +$0.07 | 1 ML | Inj, gadopiclenol, 1 ml | v1, posted September 17, 2026 |
| 3Q26 | $3.152 | −$0.068 | 1 ML | Inj, gadopiclenol, 1 ml | v1, posted September 15, 2026 |
| 2Q26 | $3.22 | −$0.078 | 1 ML | Inj, gadopiclenol, 1 ml | v1, posted September 15, 2026 |
| 1Q26 | $3.298 | −$0.066 | 1 ML | Inj, gadopiclenol, 1 ml | v1, posted September 15, 2026 |
| 4Q25 | $3.364 | −$0.043 | 1 ML | Inj, gadopiclenol, 1 ml | v1, posted September 8, 2026 |
| 3Q25 | $3.407 | −$0.065 | 1 ML | Inj, gadopiclenol, 1 ml | v1, posted March 10, 2026 |
| 2Q25 | $3.472 | −$0.109 | 1 ML | Inj, gadopiclenol, 1 ml | v1, posted March 10, 2026 |
| 1Q25 | $3.581 | −$0.587 | 1 ML | Inj gadopiclenol | v1, posted December 19, 2025 |
| 4Q24 | $4.168 | +$0.257 | 1 ML | Inj gadopiclenol | v1, posted June 11, 2025 |
| 3Q24 | $3.911 | −$1.215 | 1 ML | Inj gadopiclenol | v1, posted June 11, 2025 |
| 2Q24 | $5.126 | – | 1 ML | Inj gadopiclenol | v1, posted March 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025